Researchers at Trinity College Dublin have achieved a significant breakthrough that could lead to the development of ...

They have discovered that a vaccine adjuvant – or “booster” – called C100 promotes potent anti-tumour immunity when it is ...

Use of tumour profiling tests to determine which breast cancers require adjuvant chemotherapy is to be expanded after a NICE ...

Mark Glady, an agronomist with WinField United, highlights how crop inputs encounter numerous hurdles on their journey from ...

Puma Biotechnology announced that two abstracts for its drug Alisertib to be presented at the 2024 ASCO Annual Meeting are ...

Researchers from the Centenary Institute and the University of Sydney have made a major discovery in vaccine science, gaining ...

The World Health Organization hoped to have a treaty ready for ratification at its assembly next week. On Friday, WHO leader ...

New data add to the body of evidence favoring the aromatase inhibitor therapy plus ovarian suppression over tamoxifen for ...

A recent study found that providing immunotherapy pre- and post-surgery helps improve survival rates compared to only ...

Gabriel N. Hortabagyi, MD, FACP, provides an overview of the phase 3 NATALEE trial evaluating the combination of ribociclib ...

NeraCare, a leading developer of laboratory tests for personalized survival prediction of melanoma patients, today announced publication of an abstrac ...